Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

IDIFARMA SECURES INVESTMENT TO BOOST INTERNATIONAL GROWTH

IDIFARMA
Posted on: 13 Sep 16

SPAIN, SPAIN - Sep 12, 2016 - A Spanish contract development and manufacturing organisation (CDMO) has secured investment from Madrid-headquartered Suanfarma S.A. to further its international growth plans. 

Idifarma, which specialises in high potency development and manufacturing and spray drying to solve low solubility challenges, has grown from a small start-up business established in 2001 to a global CDMO working with more than 100 pharmaceutical companies. 

As part of a planned process to replace venture-capital financial partners, Suanfarma S.A. has acquired a stake in the CDMO. The firm has over 20 years of experience as a specialised supplier of raw materials to the pharmaceutical industry.

Luis Oquiñena, general manager and co-founder of Idifarma says: "With this announcement, Idifarma begins a new phase of growth and consolidates its position as a specialist service provider for the pharmaceutical industry in Europe. Suanfarma S.A. has a strong international presence, including the US, India, China, Brazil and Mexico, and will bring significant growth opportunities to Idifarma.

 “It’s an exciting time for our company as we celebrate 15 years since Idifarma was founded and we look forward to the months ahead." 

Suanfarma S.A. acquired its shares from three venture capital firms, while the co-founders of Idifarma remain as shareholders and in executive positions. Two local financial investors (Sodena and Caja Rural de Navarra), which have funded the company since its inception, will also remain as shareholders in order to provide stability to the CDMO in this new phase of growth.

Hector Ara, CEO of Suanfarma S.A. added: "Our partnership with Idifarma is an opportunity to contribute to the growth and strengthening of a company with which we can develop synergies that will improve our position in an increasingly competitive and demanding market.

“With a proven business model, Idifarma has huge growth potential and we plan to develop the CDMO’s percentage of international business, which already exceeds 50 per cent."

Based near Pamplona, Spain, Idifarma Desarrollo Farmacéutico, S.L. provides contract development and manufacturing services to the pharmaceutical industry. Established in 2001, the CDMO currently works with clients from across 15 countries, and specialises in highly potent drugs. 

Formed in 1993, Suanfarma S.A. is a privately held company that specialises in the development, production and marketing of raw materials for the pharmaceutical, biotechnology, veterinary, nutritional and cosmetic sectors. It has subsidiaries in the US, Latin America, Middle East and Africa and operates in more than 60 countries on all continents. 

For more information:
www.bio-itworld.com/Press-Release/IDIFARMA-SECURES-INVESTMENT-TO-BOOST-INTERNATIONAL-GROWTH

Editor's Details

Mike Wood
PharmiWeb.com
www.pharmiweb.com
editor@pharmiweb.com

Last updated on: 13/09/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.